BioCentury
ARTICLE | Clinical News

Zadaxin thymosin alpha I: Began a Phase III trial

March 7, 1994 8:00 AM UTC

SciClone Pharmaceuticals Inc. (SCLN), San Mateo, Calif. Product: Zadaxin thymosin alpha I, an immune stimulatory hormone Indication: Asymptomatic chronic hepatitis B infection Status: Began a Phase I...